Juniper Biologics discovers, develops, and manufactures biologic therapeutics such as monoclonal antibodies, recombinant proteins, and vaccine candidates using proprietary cell‑culture and protein‑engineering platforms. The company offers end‑to‑end GMP‑certified production, analytical testing, regulatory support, and flexible contract manufacturing for biotech and pharmaceutical partners, enabling faster and cost‑effective delivery of high‑quality biologics.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare systems often face shortages of high-quality biologic medicines, leading to delayed treatments and increased costs for patients with complex diseases.
Solution
Juniper Biologics operates as a pharmaceutical company focused on the discovery, development, and manufacturing of biologic therapeutics. The company leverages advanced cell‑culture and protein‑engineering platforms to create monoclonal antibodies, recombinant proteins, and vaccine candidates. By integrating end‑to‑end process development—from early‑stage research through GMP‑compliant production—Juniper Biologics aims to deliver clinically validated biologics to market more efficiently. Partnerships with biotech innovators and contract manufacturing agreements expand its pipeline and enable rapid scale‑up of promising candidates. The firm also provides regulatory consulting and supply‑chain services to ensure timely market access.
Target Audience
Primary customers include biotech firms seeking development and manufacturing partners, as well as pharmaceutical companies looking to source high‑quality biologic products for their therapeutic portfolios.
Features
- Proprietary cell‑line development and expression systems for high‑yield protein production
- GMP‑certified manufacturing facilities supporting both small‑batch clinical material and large‑scale commercial runs
- Integrated analytical suite for potency, purity, and stability testing of biologic products
- Dedicated regulatory affairs team managing IND, BLA, and global market submissions
- Flexible contract manufacturing services for external biotech partners